Antibodies, Antineutrophil Cytoplasmic
"Antibodies, Antineutrophil Cytoplasmic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
| Descriptor ID |
D019268
|
| MeSH Number(s) |
D12.776.124.486.485.114.323.190 D12.776.124.790.651.114.323.190 D12.776.377.715.548.114.323.190 D23.101.050
|
| Concept/Terms |
Antibodies, Antineutrophil Cytoplasmic- Antibodies, Antineutrophil Cytoplasmic
- Anti-Neutrophil Cytoplasmic Antibody
- Anti Neutrophil Cytoplasmic Antibody
- Antibody, Anti-Neutrophil Cytoplasmic
- Cytoplasmic Antibody, Anti-Neutrophil
- Antineutrophil Cytoplasmic Antibodies
- Cytoplasmic Antibodies, Antineutrophil
- Anti-Neutrophil Cytoplasmic Antibodies
- Anti Neutrophil Cytoplasmic Antibodies
- Antibodies, Anti-Neutrophil Cytoplasmic
- Cytoplasmic Antibodies, Anti-Neutrophil
- ANCA
- Antineutrophil Cytoplasmic Antibody
- Antibody, Antineutrophil Cytoplasmic
- Cytoplasmic Antibody, Antineutrophil
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Antineutrophil Cytoplasmic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Antineutrophil Cytoplasmic".
This graph shows the total number of publications written about "Antibodies, Antineutrophil Cytoplasmic" by people in this website by year, and whether "Antibodies, Antineutrophil Cytoplasmic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 8 | 8 | 16 |
| 2018 | 12 | 9 | 21 |
| 2019 | 3 | 4 | 7 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Antineutrophil Cytoplasmic" by people in Profiles.
-
Myeloperoxidase anti-neutrophil cytoplasmic antibody positive optic perineuritis after mRNA coronavirus disease-19 vaccine. QJM. 2021 12 20; 114(10):737-738.
-
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab. Nephrol Dial Transplant. 2021 08 27; 36(9):1758-1760.
-
Pediatric P-ANCA vasculitis following COVID-19. Pediatr Pulmonol. 2021 10; 56(10):3422-3424.
-
New onset ANCA-associated vasculitis in an adolescent during an acute COVID-19 infection: a case report. BMC Pediatr. 2021 08 05; 21(1):333.
-
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis. Rheumatology (Oxford). 2021 07 01; 60(7):3476-3477.
-
Mechanisms of thrombosis in ANCA-associated vasculitis. Clin Rheumatol. 2021 Dec; 40(12):4807-4815.
-
ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney Int. 2021 08; 100(2):473-474.
-
Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis? Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11960-11963.
-
Harmonization of antineutrophil cytoplasmic antibodies (ANCA) testing by reporting test result-specific likelihood ratios: position paper. Clin Chem Lab Med. 2020 10 16; 59(2):e35-e39.
-
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020 12; 79(12):1661-1663.